VinCRIStine Sulfate
VinCRIStine Sulfate Injection, USP
Approved
Approval ID
b22e4c8e-dbe1-4d4b-a026-e1812974071c
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Feb 1, 2023
Manufacturers
FDA
Hospira, Inc.
DUNS: 141588017
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
VINCRISTINE SULFATE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code61703-309
Application NumberANDA071484
Product Classification
M
Marketing Category
C73584
G
Generic Name
VINCRISTINE SULFATE
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateFebruary 1, 2023
FDA Product Classification
INGREDIENTS (5)
WATERInactive
Code: 059QF0KO0R
Classification: IACT
VINCRISTINE SULFATEActive
Quantity: 1 mg in 1 mL
Code: T5IRO3534A
Classification: ACTIB
MANNITOLInactive
Quantity: 100 mg in 1 mL
Code: 3OWL53L36A
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
SULFURIC ACIDInactive
Code: O40UQP6WCF
Classification: IACT